BioSpace News Archive

Agreement provides AMAG with $30 million upfront payment and eligibility to receive up to $260 million in development and commercial milestones in addition to sales royalties

Nemaura Medical, Inc., a medical technology company focused on developing micro-systems-based wearable diagnostic devices and currently commercializing sugarBEAT®, its non-invasive and flexible continuous glucose monitor, announced that it has commissioned the integration of data from third party wearable devices into its proBEAT™ app which is planned for launch in the USA later this year.

- Jakafi® demonstrated superior overall response rate in patients with steroid-refractory chronic graft-versus-host disease at Week 24 compared to best available therapy

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, will report its second quarter 2020 financial results on Thursday, August 6, 2020. Management will host a conference call and live audio webcast to discuss these results and provide a corporate update at 4:30 p.m. EDT. To participate in the conference call, please dial 1-844-646-4465 (domestic) or 1-615-24

Inovalon, a leading provider of cloud-based platforms empowering data-driven healthcare, announced a long-term engagement with Walmart’s Specialty Pharmacy business to provide cloud-based capabilities through the Inovalon ONE® Platform as part of its data-driven strategy to improve outcomes and economics for its customers.

Establishment Labs Holdings Inc. (Nasdaq: ESTA), a medical technology company focused on Women’s Health, initially in the breast aesthetics and reconstruction market, plans to announce its financial results for the quarter ended June 30, 2020 after the market closes on Thursday, August 6, 2020, and will host a conference call at 5:30 pm ET that day to discuss those results. To participate in the conference call, dial (877) 376-9925 (U.S. and Canada

Aerami Therapeutics, Inc. (the “Company”) announced today that Anne Whitaker, Chief Executive Officer, will present a corporate overview at the Private Healthcare Company Virtual Summer Symposium, hosted by LifeSci Partners, on August 4 and 5, 2020. Please click the following link to register: https://lifesci.events/SummerSymposium Presentation Details: Date: August 5, 2020 Time: 9:00 am Eastern Time About Aerami Therapeutic

Neumentum Inc., a pharmaceutical company dedicated to transforming the way pain is treated – without opioids – today provided a corporate update on notable business accomplishments and priorities for its two lead product candidates NTM-006 and NTM-001.

Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will host a live audio webcast of the Company’s 2020 Annual Meeting of Stockholders (“ASM”) on Tuesday, July 28, 2020 at 9:30 a.m. Eastern Time. Considering the coronavirus (COVID-19) pandemic, for the safety and health of Novan’s stockholders, employees and the broader community, the Company has determined that its 2020 Annual Meeting will be held solely via

Collaboration focused on developing an adjuvanted COVID-19 vaccine using Medigen’s subunit vaccine candidate with Dynavax’s CpG 1018 In preclinical testing, the combination generated strong virus neutralizing antibody responses Medigen anticipates initiating a Phase 1 clinical trial evaluating the combination in September 2020